APA (7th ed.) Citation

Aykan, M. B., Bölek, H., Yekedüz, E., Sertesen, E., Tural, D., Karaçin, C., . . . Ürün, Y. Navigating second-line therapy in metastatic renal cell carcinoma: A comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium. SAGE Publishing.

Chicago Style (17th ed.) Citation

Aykan, Musa Barış, et al. Navigating Second-line Therapy in Metastatic Renal Cell Carcinoma: A Comparative Analysis of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors: A Study of Turkish Oncology Group Kidney Cancer Consortium. SAGE Publishing.

MLA (9th ed.) Citation

Aykan, Musa Barış, et al. Navigating Second-line Therapy in Metastatic Renal Cell Carcinoma: A Comparative Analysis of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors: A Study of Turkish Oncology Group Kidney Cancer Consortium. SAGE Publishing.